Captain Sir Tom Moore: What has happened to his legacy?
How much money did Captain Tom raise and why is his family under the spotlight?
Similar Posts
Walgreens and 3 other health-care stocks are going into our Bullpen watch list
We’re making our first Bullpen update of 2024. The Bullpen is a collection of stocks identified by the CNBC Investing Club team as having the potential to join Jim Cramer’s Charitable Trust. We’re highlighting the four most interesting investment opportunities we found out of the handful of company CEOs Jim interviewed at this week’s JPMorgan…
‘Arctic zombie viruses’ could be released by climate change from thawing permafrost, some scientists claim
Join Fox News for access to this content Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the…
Black mould means girl can’t sleep in own bed, says York mother
“I’m just at the point of where I need to be out of here,” she added. ” It’s just getting too serious for me, my daughter and my unborn child.” Michael Jones, head of housing and delivery asset management at City of York Council, said mould was a common issue in many homes. “We’ve worked…
Ohio mother hopes for a cure to save her son, 8, from rare, fatal disease: ‘Gut-wrenching’
Join Fox News for access to this content Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the…
Bristol Myers Squibb to buy Karuna Therapeutics
Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock closed up more than 47% on the news Friday, hitting $317.85 a share. Bristol Myers Squibb shares closed up 2%. The deal will help expand Bristol Myers’ drug pipeline after…
Should we be worried about Covid this winter?
Experts are not too concerned about a new variant of Covid but say monitoring should continue.